Dimitrios Anastasakis
Overview
Explore the profile of Dimitrios Anastasakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enomoto Y, Li P, Jenkins L, Anastasakis D, Lyons G, Hafner M, et al.
Cancer Gene Ther
. 2021 Jul;
29(6):734-749.
PMID: 34316033
Natural killer (NK) cells play key roles in immune surveillance against tumors and viral infection. NK cells distinguish abnormal cells from healthy cells by cell-cell interaction with cell surface proteins...
2.
Grafanaki K, Skeparnias I, Kontos C, Anastasakis D, Korfiati A, Kyriakopoulos G, et al.
Pharmacogenomics J
. 2021 Jun;
21(6):638-648.
PMID: 34145402
Retinoids are widely used in diseases spanning from dermatological lesions to cancer, but exhibit severe adverse effects. A novel all-trans-Retinoic Acid (atRA)-spermine conjugate (termed RASP) has shown previously optimal in...
3.
Skeparnias I, Anastasakis D, Grafanaki K, Kyriakopoulos G, Alexopoulos P, Dougenis D, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33092114
Transcriptomics profiles of miRNAs, tRNAs or tRFs are used as biomarkers, after separate examination of several cancer cell lines, blood samples or biopsies. However, the possible contribution of all three...
4.
Anastasakis D, Benhalevy D, Hafner M
Curr Protoc Mol Biol
. 2020 May;
131(1):e120.
PMID: 32438484
During the course of their life cycle, most RNAs move between several cellular environments where they associate with different RNA binding proteins (RBPs). Reciprocally, a significant portion of RBPs reside...
5.
Grafanaki K, Anastasakis D, Kyriakopoulos G, Skeparnias I, Georgiou S, Stathopoulos C
Epigenomics
. 2018 Dec;
11(2):215-245.
PMID: 30565492
Protein synthesis is a central and dynamic process, frequently deregulated in cancer through aberrant activation or expression of translation initiation factors and tRNAs. The discovery of tRNA-derived fragments, a new...
6.
Li J, Wang X, Ackerman 4th W, Batty A, Kirk S, White W, et al.
Int J Mol Sci
. 2018 Dec;
19(12).
PMID: 30563203
Mitogen-activated protein kinase phosphatase (Mkp)-1 exerts its anti-inflammatory activities during Gram-negative sepsis by deactivating p38 and c-Jun N-terminal kinase (JNK). We have previously shown that mice, but not mice, exhibit...
7.
Tsai P, DellOrso S, Rodriguez J, Vivanco K, Ko K, Jiang K, et al.
Mol Cell
. 2018 Jul;
71(1):129-141.e8.
PMID: 29979962
The enhancer regions of the myogenic master regulator MyoD give rise to at least two enhancer RNAs. Core enhancer eRNA (eRNA) regulates transcription of the adjacent MyoD gene, whereas eRNA...
8.
Toumpeki C, Anastasakis D, Panagoulias I, Stamatopoulou V, Georgakopoulos T, Kallia-Raftopoulos S, et al.
Med Chem
. 2018 Jan;
14(6):604-616.
PMID: 29332592
Background: RNase P-mediated cleavage of target RNAs has been proposed as a promising tool for gene silencing. Ets-2 proto-oncogene controls the expression of a wide variety of genes involved in...
9.
Skeparnias I, Anastasakis D, Shaukat A, Grafanaki K, Stathopoulos C
RNA Biol
. 2017 Mar;
14(10):1320-1325.
PMID: 28267419
Deadenylases belong to an expanding family of exoribonucleases involved mainly in mRNA stability and turnover, with the exception of PARN which has additional roles in the biogenesis of several important...
10.
Anastasakis D, Skeparnias I, Shaukat A, Grafanaki K, Kanellou A, Taraviras S, et al.
Nucleic Acids Res
. 2016 Aug;
44(18):8908-8920.
PMID: 27515512
PNLDC1 is a homologue of poly(A) specific ribonuclease (PARN), a known deadenylase with additional role in processing of non-coding RNAs. Both enzymes were reported recently to participate in piRNA biogenesis...